Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
CAMBRIDGE, Mass., May 14, 2015 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies...
-
NEW YORK, April 27, 2015 (GLOBE NEWSWIRE) -- As the incidence of type 1 diabetes (T1D) rises worldwide, The Leona M. and Harry B. Helmsley Charitable Trust today announced the launch of an ambitious...
-
Participation and notification of attendance A shareholder, who wishes to participate in the meeting, must (i) be recorded as shareholder (not nominee registered) in the share register held by...
-
WASHINGTON, March 18, 2015 (GLOBE NEWSWIRE) -- BlackRock Inc. and the National Association of Corporate Directors (NACD) today announced the winners of their Global Challenge for Innovation in...
-
WAYNE, Pa., March 5, 2015 (GLOBE NEWSWIRE) -- via PRWEB - Safeguard Scientifics, Inc. (NYSE:SFE) today announced fourth quarter and full-year 2014 financial results. For the three months ended...
-
CAMBRIDGE, Mass., Feb. 27, 2015 (GLOBE NEWSWIRE) -- SAGE Therapeutics (Nasdaq:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-threatening, rare central...
-
NEEDHAM, MA--(Marketwired - Feb 24, 2015) - Widely regarded as the property insurance industry's premier thought-leadership conference, the 9th Annual Property Innovation Summit is an exclusive...
-
NEW YORK, Feb. 4, 2015 (GLOBE NEWSWIRE) -- Furnished Quarters, the largest provider of temporary apartment rentals in New York City and Boston, has announced today that Craig Partin has been promoted...
-
SAN FRANCISCO, Dec. 18, 2014 (GLOBE NEWSWIRE) -- The Mexican Museum, a Smithsonian affiliate, announces its slate of new officers for 2015. Andrew "Andy" Kluger, current Chairman of The Mexican...
-
CAMBRIDGE, Mass., Nov. 11, 2014 (GLOBE NEWSWIRE) -- SAGE Therapeutics (Nasdaq:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-threatening, rare central...